Edap TMS SA (EDAP)
7.175
+0.34
(+4.90%)
USD |
NASDAQ |
Apr 25, 13:23
Edap TMS Total Liabilities (Quarterly): 38.27M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 38.27M |
September 30, 2023 | 35.12M |
June 30, 2023 | 34.90M |
March 31, 2023 | 36.87M |
December 31, 2022 | 31.63M |
September 30, 2022 | 30.04M |
June 30, 2022 | 30.32M |
March 31, 2022 | 28.67M |
December 31, 2021 | 30.76M |
September 30, 2021 | 29.75M |
June 30, 2021 | 31.45M |
March 31, 2021 | 31.00M |
December 31, 2020 | 35.60M |
September 30, 2020 | 31.10M |
June 30, 2020 | |
March 31, 2020 | |
December 31, 2019 | 28.80M |
September 30, 2019 | |
June 30, 2019 | |
March 31, 2019 | |
December 31, 2018 | 27.20M |
September 30, 2018 | |
June 30, 2018 | 25.59M |
March 31, 2018 | |
December 31, 2017 | 26.08M |
Date | Value |
---|---|
September 30, 2017 | |
June 30, 2017 | 23.22M |
March 31, 2017 | |
December 31, 2016 | 23.41M |
September 30, 2016 | |
June 30, 2016 | 24.85M |
March 31, 2016 | |
December 31, 2015 | 26.40M |
September 30, 2015 | |
June 30, 2015 | 23.01M |
March 31, 2015 | |
December 31, 2014 | 20.69M |
September 30, 2014 | |
June 30, 2014 | 29.06M |
March 31, 2014 | |
December 31, 2013 | 24.29M |
September 30, 2013 | |
June 30, 2013 | 22.20M |
March 31, 2013 | |
December 31, 2012 | 29.47M |
September 30, 2012 | 20.64M |
June 30, 2012 | 26.53M |
March 31, 2012 | |
December 31, 2011 | 30.47M |
September 30, 2011 | 22.50M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
28.67M
Minimum
Mar 2022
38.27M
Maximum
Dec 2023
32.29M
Average
31.10M
Median
Sep 2020
Total Liabilities (Quarterly) Benchmarks
DBV Technologies SA | 42.80M |
Biophytis SA | 17.52M |
Cellectis SA | 133.58M |
Adaptimmune Therapeutics PLC | 243.10M |
NuCana PLC | 16.46M |
Total Liabilities (Quarterly) Related Metrics
Total Assets (Quarterly) | 101.20M |
Shareholders Equity (Quarterly) | 62.92M |
Debt to Equity Ratio | 0.1057 |
Current Ratio | 2.844 |
Net Debt Paydown Yield | -0.15% |